Literature DB >> 17960596

Construction of confidence limits about effect measures: a general approach.

G Y Zou1, A Donner.   

Abstract

It is widely accepted that confidence interval construction has important advantages over significance testing for the presentation of research results, as now facilitated by readily available software. However, for a number of effect measures, procedures are either not available or not satisfactory in samples of small to moderate size. In this paper, we describe a general approach for estimating a difference between effect measures, which can also be used to obtain confidence limits for a risk ratio and a lognormal mean. Numerical evaluation shows that this closed-form procedure outperforms existing methods, including the bootstrap.

Mesh:

Year:  2008        PMID: 17960596     DOI: 10.1002/sim.3095

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  25 in total

1.  Towards the estimation of effect measures in studies using respondent-driven sampling.

Authors:  Michael A Rotondi
Journal:  J Urban Health       Date:  2014-06       Impact factor: 3.671

2.  Stability of latent classes in group-based trajectory modeling of depressive symptoms in mothers of children with epilepsy: an internal validation study using a bootstrapping procedure.

Authors:  Mark A Ferro; Kathy N Speechley
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-11-10       Impact factor: 4.328

3.  Avian hosts of West Nile virus in Arizona.

Authors:  Nicholas Komar; Nicholas A Panella; Ginger R Young; Aaron C Brault; Craig E Levy
Journal:  Am J Trop Med Hyg       Date:  2013-07-15       Impact factor: 2.345

4.  Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial.

Authors:  Nigel A Cunliffe; Desiree Witte; Bagrey M Ngwira; Stacy Todd; Nancy J Bostock; Ann M Turner; Philips Chimpeni; John C Victor; A Duncan Steele; Alain Bouckenooghe; Kathleen M Neuzil
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

5.  Measuring health-related quality of life in young children with physical illness: psychometric properties of the parent-reported KIDSCREEN-27.

Authors:  Mark A Ferro; Christiane Otto; Ulrike Ravens-Sieberer
Journal:  Qual Life Res       Date:  2021-12-02       Impact factor: 4.147

6.  Sample Size Determination for Interval Estimation of the Prevalence of a Sensitive Attribute Under Randomized Response Models.

Authors:  Shi-Fang Qiu; Man-Lai Tang; Ji-Ran Tao; Ricky S Wong
Journal:  Psychometrika       Date:  2022-03-20       Impact factor: 2.500

7.  Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.

Authors:  Kiersten J Kugeler; Laura J Podewils; Nisha B Alden; Tori L Burket; Breanna Kawasaki; Brad J Biggerstaff; Holly M Biggs; Rachael Zacks; Monique A Foster; Travis Lim; Emily McDonald; Jacqueline E Tate; Rachel K Herlihy; Jan Drobeniuc; Margaret M Cortese
Journal:  Public Health Rep       Date:  2021-11-09       Impact factor: 2.792

8.  The impact of chronic physical illness, maternal depressive symptoms, family functioning, and self-esteem on symptoms of anxiety and depression in children.

Authors:  Mark A Ferro; Michael H Boyle
Journal:  J Abnorm Child Psychol       Date:  2015-01

9.  Mediated moderation of the relation between maternal and adolescent depressive symptoms: role of adolescent physical health.

Authors:  Mark A Ferro
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-08-11       Impact factor: 4.328

10.  Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.

Authors:  Sheila Isanaka; Céline Langendorf; Monica Malone McNeal; Nicole Meyer; Brian Plikaytis; Souna Garba; Nathan Sayinzoga-Makombe; Issaka Soumana; Ousmane Guindo; Rockyiath Makarimi; Marie Francoise Scherrer; Eric Adehossi; Iza Ciglenecki; Rebecca F Grais
Journal:  PLoS Med       Date:  2021-07-02       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.